2017 SUD Legislative Priorities

EMAIL info@faceaddictionmd.
org / CALL 301-525-6183
TOP Bills of Interest

For Families Coping With Substance Use Disorder
Omnibus Bills
Heroin and Opioid Prevention Effort (HOPE) and Treatment Act of 2017
House Bill 1329 / Senate Bill 967
House Sponsor: Delegate Bromwell
STATUS: House Health & Government Operations Committee:
Senate Sponsor: Senator Klausmeier
STATUS: Senate Finance Committee:
Legislation that mandates Recovery Schools, 24/7 Referral, Expanded Suboxone, Treatment in
Jails/Prisons, and more:
1. Colleges to offer credits in education for substance use disorders, effective
treatment, and pain management;
2. Establish crisis treatment centers that perform assessments 24/7 and connect
individuals to care immediately;
3. Create a Health Crisis Hotline to provide legitimate resources for callers regarding
treatment options and support services;
4. Ensure that buprenorphine is available at all "health care facilities" --hospitals,

community health centers, behavioral health treatment providers, and local health
departments;
5. Ensure that hospitals refer patients to next level of care and provide Naloxone to
surviving overdose patients;
6. Requiring all insurance providers to cover all levels of treatment, including

residential;
7. Requires the MD Dept. of Education, in consultation with stakeholders, to develop

a plan to establish regional recovery schools throughout Maryland by 12/1/2017;
8. Requires SUD treatment, incl. medicated-assisted treatment, in prisons and jails.
Heroin / Opioid Education and Community Action Act of 2017 (Start Talking Maryland)
House Sponsor: Delegate Bromwell
Legislation that mandates Expanded Drug Courts, K-12 Curriculum, Naloxone in Schools and
Parent Notification, College Prevention Program, and more:
1. Expand the use of Drug Courts;
2. Board of Education shall develop and implement a program of drug addiction and
prevention education in public schools, beginning in elementary school;
3. Establishment of school policy for school nurses to administer Naloxone, and a

requirement that parents are notified at the beginning of the school year about Naloxone
policy, and a requirement that the school develop on-going dissemination of information
re Naloxone --social media, PSA's;
4. Requires colleges to establish opioid addiction awareness and prevention training.
Prevention Bills
Limits on Opioid Prescribing (The Prescriber Limits Act of 2017)

House Bill 1432
House Sponsor: Delegate Pendergrass
Legislation that limits the amount of opiate medication that a health care provider can prescribe
at an initial consultation to a 7-day supply, unless the patient is being treated for 1) a substance-
related disorder; 2) cancer; or 3) pain related to end-of-life, or palliative care for an incurable
illness.
Licensed Pharmacists Must Notify Patients about Risks of Opioid Addiction

House Bill 988
House Sponsor: Delegate Kipke
Legislation that requires a pharmacist who is dispensing an opioid medication to notify the
patient, verbally or in writing, of the risks of opioid addiction.
Treatment Bills
Treatment at All Maryland Hospitals

House Bill 515
House Sponsor: Delegate Morhaim
STATUS: House Health & Government Operations Committee: STALLED CALL / EMAIL
ASK FOR A FAVORABLE VOTE!
Legislation that would require hospitals to establish a substance use treatment program to
identify patients in need of treatment and admit the patient to the appropriate treatment setting
or, if admission is not required, direct the patient to the appropriate outpatient treatment setting.
Hospitals would be required to provide TREATMENT ON DEMAND 24 hours a day / 7 days a
week.
Ibogaine Treatment Pilot Program

House Bill 1372
House Sponsor: Delegate Beitzel
Legislation that establishes a four-year pilot program to study Ibogaine treatment for chronic
opioid users that have tried and failed other treatment methods including opiate replacement
therapy (methadone / suboxone).
Involuntary Commitment of a Minor to Inpatient / Outpatient Treatment

Senate Bill 433
STATUS: Senate Finance Committee: Passed
STATUS: House Health & Government Operations Committee: Hearing TBA
Legislation authorizing a parent or guardian of a minor to apply for admission of the minor to a
certified inpatient or intensive outpatient alcohol and drug abuse treatment program, provided
that 1) the minor has an alcohol or drug dependency that necessitates the level of care provided
by the program; 2) the minor would benefit from treatment; and 3) the parent or guardian has
the right to be actively involved in the treatment. The minor does not have the capacity to
refuse treatment.
Involuntary Admissions and Petitions for Emergency Evaluation Modified to Include an

Adult Overdose Survivor
House Bill 1009
Legislation that enables an individual to file an emergency petition to commit an adult overdose
survivor for involuntary admission to a treatment program for evaluation, provided that the
patient has health insurance coverage as a dependent on the parent's health insurance plan.
Establishing Addiction Recovery Programs in the University System of Maryland

House Bill 590
House Sponsor: Delegate Pena-Melnyk
STATUS: Appropriations Committee: PASSED
STATUS: Senate Education, Health, and Environmental Affairs Committee: Hearing TBA
Legislation that establishes Collegiate Recovery Programs to provide support and services for
college students recovering from alcohol or drug addiction.
Patient-Centered Opioid Addiction Treatment Act

House Bill 1276
House Sponsor: Delegate Barron
Legislation that would require Opioid Treatment Programs (new term for methadone providers)
to perform the following:
1. A periodic review of a patients treatment plan with the patient, including consideration of
opioid abstinence;
2. Opioid maintenance therapy, detoxification, overdose reversal, relapse prevention, and
non-addictive medication-assisted treatment options (Vivitrol);
3. Consult with the Prescription Drug Monitoring Program (PDMP) for data on patients;
4. Provide patient education regarding ALL FDA approved opioid treatment medication
options including each options potential risks and benefits, and obtain informed
consent before prescribing any medication.
Health Care Facilities / Systems Must Have Availability of Buprenorphine Prescribers

House Bill 1278
House Sponsor: Delegate Pena-Melnyk
Legislation that requires hospitals, health centers, outpatient mental health clinics, outpatient
addiction treatment providers, and local health departments to make buprenorphine available to
patients who need it. The number of providers required would be based on the number of
patients with an opioid use disorder.
Behavioral Health Community Providers Keep the Door Open Act w/ F.A.C.E. Addiction
Amendment
Senate Bill 476 / House Bill 580
Senate Sponsor: Senator Guzzone
House Sponsor: Delegate Hayes
Legislation that would adjust the rate of Medicaid reimbursement for community mental health
and substance use providers to annual inflation rates.
F.A.C.E. Addiction asked that an amendment be considered that would tie performance
measures and treatment outcomes to reimbursement rates based on a landmark
recommendation by a national blue ribbon panel of experts to improve SUD treatment quality:
REWARD RESULTS!
Recovery Residence / Halfway House Bills

Recovery Residence Residential Rights Protection Act
Senate Sponsor: Senator Hershey
House Sponsor: Delegate Howard
Legislation that would require ASAM level 3.5 / 3.7 (detox) providers to provide an individual
with referrals to the services that are necessary to their on-going treatment and recovery (per
their ASAM assessment) prior to their discharge. This would hold recovery residences
accountable for providing the services that they say they provide.
Prohibition against Denying State Funds to Abstinence-Based Recovery Residences

House Bill 785
Legislation that prohibits the State from requiring, as a condition of acceptance of state funds,
that a recovery residence admit applicants who are receiving medication-assisted treatment for
opioid dependence.
Mandatory Urine Testing at Certified Recovery Residences

House Bill 1010
Legislation that requires Certified Recovery Residences to require employees and residents to
submit to urine testing and to keep records of results.
Naloxone Bills
Co-Prescribing Naloxone Saves Lives Act of 2017

House Sponsor: Delegate Folden
Senate Sponsor: Senator Hough
STATUS: Senate Finance Committee: STALLED CALL / EMAIL ASK FOR A
FAVORABLE VOTE!
Legislation that establishes guidelines for co-prescribing Naloxone along with certain
prescription drugs opiates and benzodiazepines, for patients who are: 1) at an elevated risk of
overdose; 2) receiving opioid therapy for chronic pain; 3) receiving a prescription for
benzodiazepines; or 4) being treated for an opioid use disorder.
Licensing of Outpatient Programs and Provision of Naloxone Kits (in hospitals, health
departments, jails and prisons)
Senate Bill 1129
Senate Sponsor: Senator Mathias
STATUS: Senate Finance Committee: Hearing 3/22 at 1:00
Legislation that mandates: 1) hospitals to provide a Naloxone kit to overdose survivors before
discharge; 2) health departments to provide a Naloxone kit to patients who have been
diagnosed with an opioid use disorder; 3) jails and prisons to provide a Naloxone kit to inmates
with a history of an opioid use disorder before release.
Prescribing and Dispensing of Naloxone Removing the DHMH Training Requirement

House Sponsor: Delegate Barron
Legislation that would remove the current DHMH requirement that individuals seeking to obtain
Naloxone be required to complete a training typically lasting an hour or more, that includes
instruction on how to recognize an overdose.
Price Gouging Prohibition for Essential Generic Drugs (including Naloxone)
Senate Sponsor: Senate President Miller
STATUS: Hearing: 2/15 Senate Finance Committee
House Sponsor: House Speaker Busch
STATUS: Hearing: 2/23 House Health & Government Operations and Economic Matters
Committees
Legislation that prohibits a manufacturer or wholesale distributor from engaging in price gouging
in the sale of an essential generic drug (including Naloxone).
Harm Reduction Bills
Safer Drug Use Facility Program

House Bill 519
Legislation that would establish Safer Drug Consumption Facility Programs that would allow
participants access to safe injecting sites where services such as needle exchange, counseling,
referral to treatment, linkages to community-based vocational and educational supports, and
other services would be available. Would presumably be located in communities with
substantial indigent chronic user populations.
Justice Reinvestment Bills

Use or Possession of Small Amounts of Any CDS a Citation not a Crime
STATUS: House Judiciary Committee: Unfavorable Vote
Senate Sponsor: Senator Muse
STATUS: Senate Judicial Proceedings Committee: Unfavorable Vote
Legislation that would make violations relating to the use or possession of small quantities of
controlled dangerous substances (CDS) a civil offense rather than a crime. Also, requires a
court to order a person who commits a violation, regardless of the age of the person; to 1)
attend a drug education program; 2) require them to get an assessment for Substance Use
Disorder (SUD); and 3) refer them to SUD treatment if necessary. Also, requires a court to
dismiss a cannabis use or possession charge if the individuals use was a medical necessity
diagnosed by a doctor.
War On Drugs Bills
30 Year Jail Sentence for Distribution of Opioids Resulting in Death w/ F.A.C.E.

Addiction Amendment
House Sponsor: House Speaker Busch
House Judiciary Committee:
Senate Sponsor: Senate President Miller
Senate Rules Committee:
Legislation which makes it a felony to distribute an opioid or opioid analogue, which leads to
overdose death, and imposes up to a 30 year jail sentence. Individual may not have directly
distributed the drug to the decedent (focuses on drug kin-pins). Defendant is immune from
criminal prosecution if he/she sought medical assistance for the person experiencing an
overdose (invokes Good Samaritan Law). Defendant is able to use the defense that he/she was
an active opioid user (their own untreated disorder caused them to resort to distribution).
F.A.C.E. Addiction asked that the bill NOT BE PASSED without an amendment that specifically
includes medical professionals found guilty of prescribing for profit among those who could be
given 30-year jail sentences.
30 Year Jail Sentence for Distribution of Heroin or Fentanyl Resulting in Death

House Bill 612
House Sponsor: Delegate Impallaria
House Judiciary Committee:
Legislation which makes it a felony to distribute heroin or fentanyl which is a contributing cause
of death and imposes up to a 30 year jail sentence. Individual may not have directly distributed
the drug to the decedent. Defendant is immune from criminal prosecution if he sought medical
assistance for the person experiencing an overdose.
Overdoses Must Be Reported to County Sheriff by Medical Professionals

House Bill 661
House Sponsor: Delegate Impallaria
House Health & Government Operations Committee:
Legislation that requires medical personnel who treat an overdose at a hospital to report the
overdose to the County Sheriff within 48 hours.

2017 SUD Legislative Priorities

Загружено:

Сведения о документе

Авторское право

Доступные форматы

Поделиться этим документом

Поделиться или встроить документ

Параметры публикации

Этот документ был вам полезен?

Это неприемлемый материал?

Авторское право:

Доступные форматы

2017 SUD Legislative Priorities

Загружено:

Авторское право:

Доступные форматы

EMAIL info@faceaddictionmd.

org / CALL 301-525-6183

TOP Bills of Interest

4. Ensure that buprenorphine is available at all "health care facilities" --hospitals,

6. Requiring all insurance providers to cover all levels of treatment, including

7. Requires the MD Dept. of Education, in consultation with stakeholders, to develop

8. Requires SUD treatment, incl. medicated-assisted treatment, in prisons and jails.

3. Establishment of school policy for school nurses to administer Naloxone, and a

4. Requires colleges to establish opioid addiction awareness and prevention training.

Limits on Opioid Prescribing (The Prescriber Limits Act of 2017)

Licensed Pharmacists Must Notify Patients about Risks of Opioid Addiction

Treatment at All Maryland Hospitals

Ibogaine Treatment Pilot Program

Involuntary Commitment of a Minor to Inpatient / Outpatient Treatment

Involuntary Admissions and Petitions for Emergency Evaluation Modified to Include an

Establishing Addiction Recovery Programs in the University System of Maryland

Patient-Centered Opioid Addiction Treatment Act

Health Care Facilities / Systems Must Have Availability of Buprenorphine Prescribers

Recovery Residence / Halfway House Bills

Prohibition against Denying State Funds to Abstinence-Based Recovery Residences

Mandatory Urine Testing at Certified Recovery Residences

Co-Prescribing Naloxone Saves Lives Act of 2017

Prescribing and Dispensing of Naloxone Removing the DHMH Training Requirement

Harm Reduction Bills

Safer Drug Use Facility Program

Justice Reinvestment Bills

30 Year Jail Sentence for Distribution of Opioids Resulting in Death w/ F.A.C.E.

30 Year Jail Sentence for Distribution of Heroin or Fentanyl Resulting in Death

Overdoses Must Be Reported to County Sheriff by Medical Professionals

Вам также может понравиться